Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Learn what you need to know about cash back taxes to optimize your financial strategies. Stay ahead in tax planning.
25,545 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Ethereum trades near the $2,000 mark as institutional moves diverge: BitMine increases ETH holdings while BTC exposur...
Quantum stocks jump on optimism about next-gen tech, yet analysts caution that lofty valuations outpace current earni...
A mediated settlement ends a years-long dispute between NEXA Lending's CEO and its former partner, yielding full cont...
Lumen Technologies plans to shave $1B in annual network costs by 2027, driven by AI-enabled operations and a broader ...
Tether unveils a Visa-enabled card tied to tokenized gold, offering XAUT rewards. The roll-out signals growing mainst...
SanDisk surged roughly 3,700% in a year, but a broad market pullback and profit-taking have funds trimming positions ...
The bond market nearing threshold as long-term yields climb in a period of geopolitical tension and data surprises. T...
As debt pressures mount, Ray Dalio warns the stock market may be flirting with bubble-like extremes seen before the 1...
Palantir’s stock has moved little over the past year despite strong revenue growth, reigniting a debate about michael...
Goldman Sachs and KeyBanc boosted AT&T price targets after the telecom giant unveiled a three-segment reporting model...
Lululemon is set to report its Q1 results tonight as margins, growth mix, and international exposure take center stag...